+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Filtration Market by Product Type, Technique Type, and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031501
  • Report
  • March 2020
  • Region: Global
  • 298 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • 3M Company
  • Amazon Filters Ltd.
  • Eaton Corporation Plc
  • Graver Technologies LLC
  • Merck & Co. Inc.
The global pharmaceutical filtration market was valued at $5,379 million in 2018, and is projected to reach $7,740 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.



Pharmaceutical filtration refers to the separation process by which unwanted particles, including solid impurities and undissolved powders, are removed from the processed materials, further resulting in the reduction of micro-organisms. Filtration is one of the important processes adopted in the pharmaceutical industry. It is used to maintain sterility of the product and check contamination in the processed solution. In addition, during the manufacturing process of active pharmaceutical ingredients (APIs), the pharmaceutical filters are utilized in several manufacturing stages. Moreover, pharmaceutical filtration is widely used for various applications such as final product processing, raw material filtration, cell separation, water purification, and air purification.

Rise in the production of biologics, large molecules, APIs, and generics; technological advancements in the pharmaceutical filters; rise in The prevalence of chronic diseases; increase in spending on R&D due to surge in government healthcare expenditure, and a rise in the number of pharmaceutical and biopharmaceutical companies across the globe are the key factors that fuel the growth of the pharmaceutical filtration market. Moreover, a rise in the adoption of innovative treatment therapies such as monoclonal antibodies, therapeutic proteins, and vaccines in the pharmaceutical industry; strong biologic pipeline products; and a rise in demand for filters in the pharmaceutical and biopharmaceutical industry are other factors that contribute toward the growth of the market. However, low income and lack of proper medical attention and large capital requirement in different countries are expected to hinder the growth of the market.

The pharmaceutical filtration market is segmented on the basis of product type, technique type, application, and region. By product type, the market is categorized into membrane filters, prefilter & depth filter media, single-use systems, catriage & capsules, filter holders, filtration accessories, and others. The membrane filters segment is further divided into MCE (mixed cellulose ester) membrane filters, coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and other membrane filters. The prefilter & depth filter media is further bifurcated into glass fiber filter and PTFE filter. According to technique type, the market is classified into microfiltration, ultrafiltration, nanofiltration, and other techniques. By applications, it is divided into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing segment is further fragmented into active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccine & antibody processing, formulation & filling solution filtration, and viral clearance. Based on region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product Type
  • Membrane Filters

  • MCE (Mixed Cellulose Ester) Membrane Filters
  • Coated Cellulose Acetate Membrane Filters
  • PTFE Membrane Filters
  • Nylon Membrane Filters
  • PVDF Membrane Filters
  • Other Membrane Filters
  • Prefilter & Depth Filter Media
  • Glass Fiber Filter
  • PTFE Filter
  • Single-Use Systems
  • Catriage & Capsules
  • Filter Holders
  • Filtration Accessories
  • Others

By Technique Type
  • Microfiltration
  • Ultrafiltration
  • Nanofiltration
  • Other Techniques

By Application
  • Final Product Processing
  • Active Pharmaceutical Ingredient Filtration
  • Sterile Filtration
  • Protein Purification
  • Vaccine and Antibody Processing
  • Formulation and Filling Solution Filtration
  • Viral Clearance
  • Raw Material Filtration
  • Cell Separation
  • Water Purification
  • Air Purification

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • 3M Company
  • Amazon Filters Ltd.
  • Danaher Corporation (Pall Corporation)
  • Eaton Corporation Plc
  • General Electric Company (GE Healthcare)
  • Graver Technologies, LLC
  • Meissner Filtration Products, Inc.
  • Merck & Co., Inc.
  • Parker-Hannifin Corporation
  • Sartorius Stedim Biotech S.A.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • The Marmon Group LLC.
  • Fabtech Technologies International
  • ErtelAlsop
Frequently Asked Questions about the Global Pharmaceutical Filtration Market

What is the estimated value of the Global Pharmaceutical Filtration Market?

The Global Pharmaceutical Filtration Market was estimated to be valued at $5379.0 million in 2018.

What is the growth rate of the Global Pharmaceutical Filtration Market?

The growth rate of the Global Pharmaceutical Filtration Market is 4.7%, with an estimated value of $7740.0 million by 2026.

What is the forecasted size of the Global Pharmaceutical Filtration Market?

The Global Pharmaceutical Filtration Market is estimated to be worth $7740.0 million by 2026.

Who are the key companies in the Global Pharmaceutical Filtration Market?

Key companies in the Global Pharmaceutical Filtration Market include 3M Company, Amazon Filters Ltd., Danaher Corporation (Pall Corporation), Eaton Corporation Plc, General Electric Company (GE Healthcare), Graver Technologies LLC, Meissner Filtration Products Inc., Merck & Co. Inc. and Hannifin Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Amazon Filters Ltd.
  • Eaton Corporation Plc
  • Graver Technologies LLC
  • Merck & Co. Inc.

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in production of biologics and large molecules
3.4.1.2. Expansion of biopharmaceutical industry
3.4.1.3. Increase in government expenditure on healthcare
3.4.2. Restraint
3.4.2.1. Poor demand in under developed countries
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis
CHAPTER 4: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Membrane filters
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.5. MCE (Mixed Cellulose Ester) membrane filters
4.2.5.1. Market size and forecast
4.2.6. Coated cellulose acetate membrane filters
4.2.6.1. Market size and forecast
4.2.7. PTFE membrane filters
4.2.7.1. Market size and forecast
4.2.8. Nylon membrane filters
4.2.8.1. Market size and forecast
4.2.9. PVDF membrane filters
4.2.9.1. Market size and forecast
4.2.10. Other membrane filters
4.2.10.1. Market size and forecast
4.3. Prefilter & depth filter media
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Single-use systems
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Catriage & capsules
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Filter holders
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Filtration accessories
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Others
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
CHAPTER 5: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Microfiltration
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Ultrafiltration
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Nanofiltration
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Other Techniques
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Final Product Processing
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.2.3. Market size and forecast, by type
6.2.4. Active pharmaceutical ingredient filtration
6.2.4.1. Market size and forecast
6.2.5. Sterile filtration
6.2.5.1. Market size and forecast
6.2.6. Protein purification
6.2.6.1. Market size and forecast
6.2.7. Vaccine & Antibody Processing
6.2.7.1. Market size and forecast
6.2.8. Others
6.2.8.1. Market size and forecast
6.3. Raw material filtration
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Cell separation
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Water purification
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Air Purification
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
CHAPTER 7: PHARMACEUTICAL FILTRATION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U. S.
7.2.2.1.1. U. S. pharmaceutical filtration market, by product
7.2.2.1.2. U. S. pharmaceutical filtration market, by technique
7.2.2.1.3. U. S. pharmaceutical filtration market, by application
7.2.2.2. Canada
7.2.2.2.1. Canada pharmaceutical filtration market, by product
7.2.2.2.2. Canada pharmaceutical filtration market, by technique
7.2.2.2.3. Canada pharmaceutical filtration market, by application
7.2.2.3. Mexico
7.2.2.3.1. Mexico pharmaceutical filtration market, by product
7.2.2.3.2. Mexico pharmaceutical filtration market, by technique
7.2.2.3.3. Mexico pharmaceutical filtration market, by application
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by technique
7.2.5. North America market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany pharmaceutical filtration market, by product
7.3.2.1.2. Germany pharmaceutical filtration market, by technique
7.3.2.1.3. Germany pharmaceutical filtration market, by application
7.3.2.2. France
7.3.2.2.1. France pharmaceutical filtration market, by product
7.3.2.2.2. France pharmaceutical filtration market, by technique
7.3.2.2.3. France pharmaceutical filtration market, by application
7.3.2.3. UK
7.3.2.3.1. UK pharmaceutical filtration market, by product
7.3.2.3.2. UK pharmaceutical filtration market, by technique
7.3.2.3.3. UK pharmaceutical filtration market, by application
7.3.2.4. Italy
7.3.2.4.1. Italy pharmaceutical filtration market, by product
7.3.2.4.2. Italy pharmaceutical filtration market, by technique
7.3.2.4.3. Italy pharmaceutical filtration market, by application
7.3.2.5. Spain
7.3.2.5.1. Spain the pharmaceutical filtration market, by product
7.3.2.5.2. Spain the pharmaceutical filtration market, by technique
7.3.2.5.3. Spain the pharmaceutical filtration market, by application
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe pharmaceutical filtration market, by product
7.3.2.6.2. Rest of Europe pharmaceutical filtration market, by technique
7.3.2.6.3. Rest of Europe pharmaceutical filtration market, by application
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by technique
7.3.5. Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan pharmaceutical filtration market, by product
7.4.2.1.2. Japan pharmaceutical filtration market, by technique
7.4.2.1.3. Japan pharmaceutical filtration market, by application
7.4.2.2. China
7.4.2.2.1. China pharmaceutical filtration market, by product
7.4.2.2.2. China pharmaceutical filtration market, by technique
7.4.2.2.3. China pharmaceutical filtration market, by application
7.4.2.3. Australia
7.4.2.3.1. Australia pharmaceutical filtration market, by product
7.4.2.3.2. Australia pharmaceutical filtration market, by technique
7.4.2.3.3. Australia pharmaceutical filtration market, by application
7.4.2.4. India
7.4.2.4.1. India pharmaceutical filtration market, by product
7.4.2.4.2. India pharmaceutical filtration market, by technique
7.4.2.4.3. India pharmaceutical filtration market, by application
7.4.2.5. South Korea
7.4.2.5.1. South Korea pharmaceutical filtration market, by product
7.4.2.5.2. South Korea pharmaceutical filtration market, by technique
7.4.2.5.3. South Korea pharmaceutical filtration market, by application
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific pharmaceutical filtration market, by product
7.4.2.6.2. Rest of Asia-Pacific pharmaceutical filtration market, by technique
7.4.2.6.3. Rest of Asia-Pacific pharmaceutical filtration market, by application
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by technique
7.4.5. Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil pharmaceutical filtration market, by product
7.5.2.1.2. Brazil pharmaceutical filtration market, by technique
7.5.2.1.3. Brazil pharmaceutical filtration market, by application
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia pharmaceutical filtration market, by product
7.5.2.2.2. Saudi Arabia pharmaceutical filtration market, by technique
7.5.2.2.3. Saudi Arabia pharmaceutical filtration market, by application
7.5.2.3. South Africa
7.5.2.3.1. South Africa pharmaceutical filtration market, by product
7.5.2.3.2. South Africa pharmaceutical filtration market, by technique
7.5.2.3.3. South Africa pharmaceutical filtration market, by application
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA pharmaceutical filtration market, by product
7.5.2.4.2. Rest of LAMEA pharmaceutical filtration market, by technique
7.5.2.4.3. Rest of LAMEA pharmaceutical filtration market, by application
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by technique
7.5.5. LAMEA market size and forecast, by application
CHAPTER 8: COMPANY PROFILES
8.1.3M Company
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Amazon Filters Ltd.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. Danaher Corporation (Pall Corporation)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Eaton Corporation Plc
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. General Electric Company (GE Healthcare)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Graver Technologies, LLC
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. Meissner Filtration Products, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. Merck & Co. , Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Parker-Hannifin Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Sartorius Stedim Biotech S. A.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Amazon Filters Ltd.
  • Eaton Corporation Plc
  • Graver Technologies LLC
  • Merck & Co. Inc.
According to this report titled, 'Pharmaceutical Filtration Market by Product Type, Technique Type, and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026,' the global pharmaceutical filtration market size was valued at $5,379 million in 2018, and is projected to reach$7,740 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026.

Pharmaceutical filtration is defined as a filtration process to separate suspended particles from a medium or solution by passing them through a membrane. They reduce or eliminate the bacteria or other microorganisms in process components. The filtration process can be combined with other pharmaceutical manufacturing operations. Pharmaceutical filters are used in the production of small molecule ingredients such as active pharmaceutical ingredients (APIs) and pharmaceutical excipients. In addition, it is utilized in manufacturingof variety of dosage forms such as tablets, capsules, injectable, solutions, and others. Furthermore, it is used in many processes such as final product processing, raw material filtration, cell separation, water purification, and air purification.

The major factors that boost the growth of the global pharmaceutical filtration market includetechnological advancements in the pharmaceutical filters;surge in the production of biologics, large molecules, APIs, and generics;rise in spending on R&D due to the rise in government healthcare expenditure;increasein incidence of various diseases such as dengue, chikungunya, and malaria; and risein demand for filters in the pharmaceutical and biopharmaceutical industry. In addition, strong biologic pipeline products;increase in adoption of innovative treatment therapies such as monoclonal antibodies, therapeutic proteins, and vaccines in the pharmaceutical industry; and a rise in the number of pharmaceutical and biopharmaceutical companies across the globe are further expected to boost the market growth during the forecast period. However, large capital requirement and low income and lack of proper medical attention in the developing countries hamper the growth of the pharmaceutical filtration market.

Based on product type, the market is categorized into membrane filters, prefilter & depth filter media, single-use systems, catriage & capsules, filter holders, filtration accessories, and others. Presently, membrane filters dominates the global market, and is anticipated to continue this trend duringthe forecast period. The key factors that drivethe market growth includeincrease versatility & efficiency, lower operation costs, high performance, ease of use, and a rise in demand for good
manufacturing practices (GMP) and single-use technologies in the pharmaceutical industry.

According to technique type, the market is classified intomicrofiltration, ultrafiltration, nanofiltration, and other techniques. Currently, microfiltration segment is the major shareholder in the global pharmaceutical filtration market, owing to technological advancements in microfiltration process, rise in the pharmaceuticals and processed food industries, and an increase in awareness regarding water quality. In addition, advantages offered by microfiltration process are low operating pressure, relatively cheap, low energy consumption as compared to nano-filtration osmosis, and few manual actions required during the filtration process.

By application, the final product processing accounted for the highest revenue share in the pharmaceutical filtration market in 2018, and is expected to maintain its dominance during the forecast period. This is attributed to rise number of pharmaceutical industries, increasein the use of biologic drug products, surge in the use of filters in protein purification process, and technological advancement in filtration process. In addition, strong presence of pipeline monoclonal antibodies and commercial availability of monoclonal antibodies are expected to offer remunerative opportunities for the market expansion in the near future.

According to Onkar Sumant, Manager, Healthcare, “The growth of the pharmaceutical filtration market is attributed to increase in demand for filters in the pharmaceutical and biopharmaceutical industry. Furthermore, rise in the production of biologics, large molecules, APIs, and generics and an increase in number of pharmaceutical and biopharmaceutical companies across the globeare the other factors that contribute to the growth of the market.”

KEY FINDINGS OF THE STUDY
  • Based on product type, the membrane filters segment held more than one forth share in the global market in 2018.
  • By technique type, the microfiltrationsegment accounted for the largest market share in 2018, and is expected to remain dominant throughout the forecast period.
  • Based on application, the final product processingsegment held more than one forth share in the global market in 2018.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.2% during the forecast period.

In 2018, North America accounted for the major share in the pharmaceutical filtration market, and is expected to continue this trend during the forecast period, owing to availability of well-developed infrastructure, higher number of R&D activities with large presence of key players, rise in demand for filters in the pharmaceutical industry, surge in production of biologics and generics, and an increase in non-government & government initiatives to promote healthcare. However, Asia-Pacific is expected to register the highest growth in the coming future, owing to improvement in healthcare infrastructure, technological advancements in the field of healthcare, and the developing R&D sector.
Note: Product cover images may vary from those shown
  • 3M Company
  • Amazon Filters Ltd.
  • Danaher Corporation (Pall Corporation)
  • Eaton Corporation Plc
  • General Electric Company (GE Healthcare)
  • Graver Technologies LLC
  • Meissner Filtration Products Inc.
  • Merck & Co. Inc.
  • Parker-Hannifin Corporation
  • Sartorius Stedim Biotech S.A
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...